Teva's Biosimilar Boom Just Beginnings: Is It Time to Buy?
Teva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
Find out Which Dividend Growth ETF Has Low Fees and what to look for in expense ratios. Get tips to compare funds effectively.
28,299 articlesTeva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
Stellantis faces a pivotal push to revive overseas markets and lift investor confidence. This deep-dive explores the ...
Lithium Americas has gained 32% in the last year as Thacker Pass advances, but rising share dilution and mounting cap...
A 130-day tenure ends as the white house crypto czar departs, leaving a policy footprint that favors banks and infras...
Vornado Realty Trust CEO Steven Roth used a quarterly earnings call to harshly rebuke New York City's tax agenda, cal...
Korea’s tech-heavy KOSPI has surged roughly 75% since January, outpacing even the hottest Nasdaq plays. The year’s be...
alanis morissette quickly sells a Bay Area estate for $9.6 million, signaling momentum in the luxury market. The sale...
A Twitch-origin creator lands Brazil’s World Cup rights, beating Globo and igniting a streaming-first era. The move r...
Binance is stepping up talks with European regulators to win a MiCA license, aiming to keep services flowing across t...
Turning Point Brands stock has fallen today even after a strong quarterly report. This article explains what happened...
Pinterest sparked a noticeable stock move after its Q1 results, but a single quarter rarely writes the full comeback ...
The Federal Communications Commission announced an enforcement action against The View over possible equal-time viola...